Home
/
Oncology Institute, Inc.
/
Financials
/
Quarterly
Oncology Institute, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Oncology Institute, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$136.56M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$119.80M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$104.41M
May 14, 2025
Q3
2025
Sep 30, 2024
$99.90M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$98.58M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$94.67M
May 14, 2025
Q3
2024
Sep 30, 2023
$82.04M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$80.22M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$76.19M
May 14, 2024
Q3
2023
Sep 30, 2022
$64.98M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$60.92M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$55.16M
May 10, 2023
Q3
2022
Sep 30, 2021
$52.28M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$49.84M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$48.58M
May 10, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($16.50M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($17.01M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($17.01M)
Nov 13, 2025
Q3
2025
Mar 31, 2025
($19.59M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($19.59M)
May 14, 2025
Q2
2025
Mar 31, 2025
($19.59M)
Aug 13, 2025
Q3
2025
Sep 30, 2024
($16.11M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($15.48M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($15.48M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($19.89M)
May 14, 2025
Q2
2025
Mar 31, 2024
($19.89M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($19.89M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($17.42M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($16.90M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($16.90M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($30.00M)
May 14, 2024
Q2
2024
Mar 31, 2023
($30.00M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($30.00M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($2.67M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($5.45M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.05M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($11.21M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($9.91M)
May 14, 2025
Q3
2025
Sep 30, 2024
($13.85M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.36M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($17.97M)
May 14, 2025
Q3
2024
Sep 30, 2023
($13.93M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($14.94M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($32.87M)
May 14, 2024
Q3
2023
Sep 30, 2022
($20.10M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($18.30M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($18.47M)
May 10, 2023
Q3
2022
Sep 30, 2021
($2.16M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($1.12M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($1.75M)
May 10, 2022
Q3
2021
Sep 30, 2020
($198.5K)
Dec 14, 2021
Q2
2021
Jun 30, 2020
($194.6K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($87.8K)
May 28, 2021